Project HERCULES team
Project HERCULES is led by Duchenne UK.
Its Steering Group is chaired by Fleur Chandler, Head of Market Access at Sanofi, whose son Dominic has Duchenne muscular dystrophy (DMD).
The Project Director is Josie Godfrey, who led work to establish the UK’s Health Technology Assessment programme for rare diseases at the National Institute for Health and Care Excellence (NICE).
The Project HERCULES Steering Group is the decision-making body which oversees the delivery of the objectives of Project HERCULES. The group meets twice a year. It is comprised of the Project HERCULES team members and the following companies, patient groups, advisors and vendors.
